Diploma (LON:DPLM – Get Free Report) had its price objective lifted by JPMorgan Chase & Co. from GBX 5,760 to GBX 8,250 in a report released on Monday,London Stock Exchange reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective suggests a potential upside of 13.25% from the company’s current price.
Several other equities analysts have also commented on DPLM. Deutsche Bank Aktiengesellschaft upped their price target on shares of Diploma from GBX 6,400 to GBX 7,200 and gave the stock a “buy” rating in a research report on Wednesday, May 20th. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 9,000 target price on shares of Diploma in a research report on Monday, July 20th. Jefferies Financial Group reaffirmed a “hold” rating and issued a GBX 7,000 target price on shares of Diploma in a research report on Friday, May 29th. Finally, Royal Bank Of Canada boosted their price target on Diploma from GBX 7,300 to GBX 7,400 and gave the company an “outperform” rating in a research report on Friday, July 17th. Six investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of GBX 7,400.
Get Our Latest Research Report on Diploma
Diploma Trading Up 1.5%
Insider Transactions at Diploma
In other Diploma news, insider Mandy Gradden bought 1,000 shares of the business’s stock in a transaction dated Friday, July 17th. The shares were acquired at an average price of GBX 7,183 per share, with a total value of £71,830. Also, insider Wilson Ng bought 424 shares of Diploma stock in a transaction that occurred on Thursday, July 16th. The shares were acquired at an average price of GBX 7,066 per share, for a total transaction of £29,959.84. Insiders acquired 1,604 shares of company stock valued at $11,447,718 over the last 90 days. Corporate insiders own 1.14% of the company’s stock.
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Articles
- Five stocks we like better than Diploma
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
